Evidence map›Paper›PMID 22579728›Full record

ArticleMolecular and cellular neurosciences2012

Dynamic expression of ganglion cell markers in retinal progenitors during the terminal cell cycle.

Lev Prasov, Tom Glaser

Abstract read
In one paragraph

Article in Molecular and cellular neurosciences, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. TheProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  8. A Novel Reporter Mouse Uncovers Endogenous Brn3b Expression.International journal of molecular sciences · 2019
    Article
  9. Review
  10. Article
  11. The multisystemic functions of FOXD1 in development and disease.Journal of molecular medicine (Berlin, Germany) · 2018
    Review
  12. Different Effect ofFrontiers in genetics · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Two transcription factors, Pou4f2 and Isl1, are sufficient to specify the retinal ganglion cell fate.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lev PrasovDepartment of Human Genetics, University of Michigan, Ann Arbor, MI 48109, United States.
Tom Glaser
University of Michigan–Ann Arbor · US

Funding

MICHIGAN MEDICAL SCIENTIST TRAINING PROGRAMT32GM007863 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COLLINS, KATHLEEN L. · 1985 to 2024
$38.3M
Vision Research Training Program - T32EY013934T32EY013934 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Patrice Elie Fort · 2002 to 2026
$4.2M
Genetic Analysis of Retinal Ganglion Cell Function, Development and DiseaseR01EY014259 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GLASER, THOMAS M. · 2002 to 2013
$2.8M
NEI NIH HHS R01 EY014259NEI NIH HHS R01 EY14259NEI NIH HHS T32 EY013934NEI NIH HHS T32 EY13934NIGMS NIH HHS T32 GM007863NIGMS NIH HHS T32 GM07863
6 · The paper itself

Abstract

The vertebrate neural retina contains seven major cell types, which arise from a common multipotent progenitor pool. During neurogenesis, these cells stop cycling, commit to a single fate, and differentiate. The mechanism and order of these steps remain unclear. The first-born type of retinal neurons, ganglion cells (RGCs), develop through the actions of Math5 (Atoh7), Brn3b (Pou4f2) and Islet1 (Isl1) factors, whereas inhibitory amacrine and horizontal precursors require Ptf1a for differentiation. We have examined the link between these markers, and the timing of their expression during the terminal cell cycle, by nucleoside pulse-chase analysis in the mouse retina. We show that G2 phase lasts 1-2 h at embryonic (E) 13.5 and E15.5 stages. Surprisingly, we found that cells expressing Brn3b and/or Isl1 were frequently co-labeled with EdU after a short chase (<1 h) in early embryos (<E14), indicating that these factors, which mark committed RGCs, can be expressed during S or G2 phases. However, during late development (>E15), Brn3b and Isl1 were exclusively expressed in post-mitotic cells, even as new RGCs are still generated. In contrast, Ptf1a and amacrine marker AP2α were detected only after terminal mitosis, at all developmental stages. Using a retroviral tracer in embryonic retinal explants (E12-E13), we identified two-cell clones containing paired ganglion cells, consistent with RGC fate commitment prior to terminal mitosis. Thus, although cell cycle exit and fate determination are temporally correlated during retinal neurogenesis, the order of these events varies according to developmental stage and final cell type.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsBiomarkersCell CycleCell DifferentiationHomeodomain ProteinsLIM-Homeodomain ProteinsMiceNerve Tissue ProteinsRetinaRetinal NeuronsStem CellsTranscription Factor Brn-3BTranscription FactorsAtoh7 protein, mouseBasic Helix-Loop-Helix ProteinsBiomarkersHomeodomain Proteinsinsulin gene enhancer binding protein Isl-1LIM-Homeodomain ProteinsNerve Tissue ProteinsPou4f2 protein, mouseTranscription Factor Brn-3BTranscription Factors

Identifiers

PMID22579728
PMCPMC3383354
OpenAlexW2053133897

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.